Picture of Accelerate Diagnostics logo

AXDXQ — Accelerate Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Accelerate Diagnostics Sees Q4 2020 Revenue About $3.1 Million

Jan 12 (Reuters) - Accelerate Diagnostics Inc  AXDX.O :
    * ACCELERATE DIAGNOSTICS ANNOUNCES PRELIMINARY FOURTH
QUARTER AND
FULL-YEAR 2020 FINANCIAL RESULTS
    * SEES Q4 2020 REVENUE ABOUT $3.1 MILLION
    * SEES FY 2020 REVENUE $11.2 MILLION
    * ADDED 45 LIVE INSTRUMENTS IN Q4
    * GROSS MARGIN IS EXPECTED TO BE APPROXIMATELY 40% FOR
FULL-YEAR
2020
    * NET CASH USED IS EXPECTED TO BE APPROXIMATELY $41 MILLION
FOR
FULL-YEAR 2020
    * ACCELERATE DIAGNOSTICS-CONTRACTED 21 INSTRUMENTS WITH NEW
CUSTOMERS IN Q4, RESULTING IN YEAR-END BACKLOG OF 133 PHENO
INSTRUMENTS PENDING GO-LIVE IN U.S
    * Q4 REVENUE VIEW $4.4 MILLION -- REFINITIV IBES DATA
    * FY2020 REVENUE VIEW $12.4 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn73FslWa 
Further company coverage:  AXDX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Accelerate Diagnostics

See all news